Literatur

1 Ahlijanian MK, Barrazueta NX et al.: Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci USA. 2000, 97, 2910-2915,

2 Arendt T, Brückner MK et al.: Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of platsic remodeling in the adult brain. Neurosci. 1998, 43, 991-1002,

3 Auer IA, Schmidt ML et al.: Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease. Acta neuropathol. 1995, 90, 547-551,

4 Bachman DL, Wolf PA et al.: Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study. Neurology. 1993, 43, 515-519,

5 Bancher C, Brunner C et al.: Accumulation of abnormally phosphorylated tau precedes formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 1989, 477, 90-99,

6 Bancher C, Jellinger K et al.: Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia. Eur Arch Psychiatry Clin Neurosci. 1996, 246, 137-146,

7 Billingsley ML, Kincaid RL: Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J. 1997, 323, 577-591,

8 Blass JP: Pathophysiology of Alzheimer's syndrome. Neurology. 1993, 43(Suppl 4), S25-S38,

9 Börnig H, Geyer G: Staining of cholesterol with the fluorescent antibiotic "filipin". Acta histochem. 1974, 50, 110-115,

10 Braak E, Braak H, Mandelkow EM: A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta neuropathol. 1994, 87, 554-567,

11 Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta neuropathol. 1991, 82, 239-259,

12 Brown MS, Goldstein JL: Multivalent feedback regulation of HMGCoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res. 1980, 21, 505-517,

13 Brown MS, Goldstein JL: A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA. 1999, 96, 11041-11048,


[Seite 52↓]

14 Carstea ED, Morris JA et al.: Niemann-Pick C1 gene: homology to mediators of cholesterol homeostasis. Sci. 1997, 277, 228-231,

15 Cataldo AM, Barnett JL et al.: Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci. 1997, 17, 6142-6151,

16 Cataldo AM, Peterhoff CM et al.: Endocytic pathway abnormalities precede beta-amyloid deposition in sporadic Alzheimer's disease: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000, 157, 277-286,

17 Corder EH, Saunders AM et al.: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late omset families. Sci. 1993, 261, 921-923,

18 Cruz JC, Sugii S et al.: Role of Niemann-Pick type C1 protein in intracellular trafficking of low density lipoprotein-derived cholesterol. J Biol Chem. 2000, 275, 4013-4021,

19 Davies RA, Chen FW, Ioannou YA: Transmembrane molecular pump activity of Niemann-Pick C1 protein. Sci. 2000, 290, 2295-2298,

20 Demel RA, de Kruyff B: The function of sterols in membranes. Biochim Biophys Acta. 1976, 457, 109-132,

21 Dietschy JM: Overview of cholesterol and lipoprotein metabolism in the brain, liver and extrahepatic organs. Nutr Metab Cardiovasc Dis. 1997, 7, 162-168,

22 Doll R: Review: Alzheimer's disease and environmental survival bias. Age Ageing. 1993, 22, 138-153,

23 Edlund C, Söderberg M, Kristensson K: Isoprenoids in aging and neurodegeneration. Neurochem Int. 1994, 25, 35-38,

24 Elleder M, Jirasek A, Smid F: Niemann-Pick disease (Crocker's type C) - a histochemical study of the distribution and of qualitative differences of the storage process. Acta neuropathol. 1975, 33, 191-200,

25 Elleder M, Jirasek A, Smid F et al.: Niemann-Pick disease type C - study on the nature of the cerebral storage process. Acta neuropathol. 1985, 66, 325-336,

26 Esler WP, Wolfe MS: A portrait of Alzheimer secretases - new features and familiar faces. Sci. 2001, 293, 1449-1454,

27 Fielding CJ, Fielding PE: Intracellular cholesterol transport. J Lipid Res. 1997, 38, 1503-1521,

28 Friedhoff P, von Bergen M et al.: Structure of tau protein and assembly into paired helical filaments. Biochim Biophys Acta. 2000, 1502, 122-132,


[Seite 53↓]

29 Gärtner U, Holzer M, Arendt T: Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neurosci. 1999, 91, 1-5,

30 Georgieff IS, Liem RKH et al.: Expression of high molecular weight tau in the central and peripheral nervous systems. J Cell Sci. 1993, 105, 729-737,

31 Gertz HJ, Krüger H et al.: Tangle-bearing neurons show more extensive dendritic trees than tangle-free neurons in area CA1 of the hippocampus in Alzheimer's disease. Brain Res. 1991, 548, 260-266,

32 Ghetti B, Tagliavini F et al.: Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology. 1989, 39, 1453-1461,

33 Gilbert EF, Callahan J et al.: Niemann-Pick disease type C - pathological, histochemical, ultrastructural and biochemical studies. Eur J Pediatr. 1981, 136, 263-271,

34 Goate AM: Molecular genetics of Alzheimer's disease. Geriatrics. 1997, 52, S9-S12,

35 Goedert M: Tau protein and the neurofibrillary pathology of Alzheimer's disease. Ann N Y Acad Sci. 1996, 777, 121-131,

36 Goedert M, Jakes R et al.: Assembly of microtubule-related protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature. 1996, 383, 550-553,

37 Grana X, Reddy PE: Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 1995, 11, 211-219,

38 Grundke-Iqbal I, Iqbal K et al.: Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA. 1986, 83, 4913-4917,

39 Halliday WC, Chudley AE: 18q-syndrome: neurofibrillary tangles without neuritic plaques. J Neuropathol Exp Neurol. 1989, 48, 308,

40 Harik SI, Kalaria RN: Blood-brain border abnormalities in Alzheimer's disease. Ann N Y Acad Sci. 1991, 640, 47-52,

41 Haroutunian V, Purohit DP et al.: Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol. 1999, 56, 713-718,

42 Harzer K, Schlote W et al.: Neurovisceral lipidosis compatible with Niemann-Pick disease type C: morphological and biochemical studies of a late infantile case and enzyme and lipid assays in a prenatal case of the same family. Acta neuropathol. 1978, 43, 97-104,


[Seite 54↓]

43 Hassall DG, Graham A: Changes in free cholesterol content, measured by filipin fluorescence and flow cytometry, correlate with changes in cholesterol biosynthesis in THP-1 macrophages. Cytometry. 1995, 21, 352-362,

44 Henderson LP, Lin L et al.: Embryonic striatal neurons from Niemann-Pick type C mice exhibit defects in cholesterol metabolism and neurotrophin responsiveness. J Biol Chem. 2000, 275, 20179-29187,

45 Higgins JJ, Patterson MC et al.: A clinical staging classification for type C Niemann-Pick disease. Neurology. 1992, 42, 2286-2290,

46 Hirano A, Malamud N et al.: Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam. Arch Neurol. 1966, 15, 35-51,

47 Hof PR, Bouras C et al.: Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta neuropathol. 1992, 85, 23-30,

48 Horoupian DS, Yang SS: Paired helical filaments in neurovisceral lipidosis (juvenile dystonic lipidosis). Ann Neurol. 1978, 4, 404-411,

49 Hoyer S: Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease. Acta Neurol Scand Suppl. 1996, 165, 18-24,

50 Illenberger S, Zheng-Fischhöfer Q et al.: The endogenous and cell-cylce dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol Biol Cell. 1998, 9, 1495-1512,

51 Kabara JJ: A critical review of brain cholesterol metabolism. Prog Brain Res. 1973, 40, 363-382,

52 Kabouridis PS, Janzen J et al.: Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes. Eur J Immunol. 2000, 30, 954-963,

53 Ko DC, Gordon MD et al.: Dynamic movements of organelles containing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events. Mol Biol Cell. 2001, 12, 601-614,

54 Kölsch H, Ludwig M et al.: Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta. J Neural Transm. 2001, 108, 475-488,

55 Kölsch H, Lütjohann D et al.: The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. Brain Res. 1999, 818, 171-175,

56 Kruth HS, Vaughan M: Quantification of low density lipoprotein binding and cholesterol accumulation by single human fibroblasts using fluorescence microscopy. J Lipid Res. 1980, 21, 123-130,


[Seite 55↓]

57 Kunze K: Lehrbuch der Neurologie. Stuttgart, 1992

58 Lange Y, Ye J et al.: Dynamics of lysosomal cholesterol in Niemann-Pick type C and normal human fibroblasts. J Lipid Res. 2002, 43, 198-204,

59 Lee VMY, Balin BJ et al.: A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Sci. 1991, 251, 675-678,

60 Lizard G, Gueldry S et al.: Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J. 1998, 12, 1651-1663,

61 Love S, Bridges LR, Case CP: Neurofibrillary tangles in Niemann-Pick disease type C. Brain. 1995, 118, 119-129,

62 Lund EG, Gulleyardo JM, Russell DW: cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in brain. Proc Natl Acad Sci USA. 1999, 96, 7238-7243,

63 Lusa S, Blom TS et al.: Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. J Cell Sci. 2001, 114, 1893-1900,

64 Lütjohann D, Breuer O et al.: Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain to the circulation. Proc Natl Acad Sci USA. 1996, 93, 9799-9804,

65 Lynch C, Mobley W: Comprehensive theory of Alzheimer's disease: the effects of cholesterol on membrane receptor trafficking. Ann N Y Acad Sci. 2000, 924, 104-111,

66 Mandelkow EM, Schweers O et al.: Structure, microtubule interactions, and phosphorylation of tau protein. Ann N Y Acad Sci. 1996, 777, 96-106,

67 Markesbery WR: Oxidative stress hypothesis in Alzheimer's disease. Free Rad Biol Med. 1997, 23, 134-147,

68 Masliah E, Terry RD, Alford M et al.: Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am J Pathol. 1991, 138, 235-246,

69 Masliah E, Terry RD, Mallory M et al.: Diffuse plaques do not accentuate synpase loss in Alzheimer's disease. Am J Pathol. 1990, 137, 1293-1297,

70 Mauch DH, Nägler K et al.: CNS synaptogenesis promoted by glia-derived cholesterol. Sci. 2001, 294, 1354-1357,


[Seite 56↓]

71 Mercken M, Vandermeeren M et al.: Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta neuropathol. 1992, 84, 265-272,

72 Mori T, Paris D et al.: Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APPSW mice. J Neuropathol Exp Neurol. 2001, 60, 778-785,

73 Mortimer JA, French LR et al.: Head injury as a risk factor for Alzheimer's disease. Neurology. 1985, 35, 264-267,

74 Nagy Z, Esiri MM, Cato AM et al.: Cell cycle markers in the hippocampus in Alzheimer's disease. Acta neuropathol. 1997, 94, 6-15,

75 Nagy Z, Esiri MM, Jobst KA et al.: Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neurosci. 1995, 69, 757-761,

76 Nagy Z, Esiri MM, Smith AD: The cell division cycle and the pathophysiology of Alzheimer's disease. Neurosci. 1998, 87, 731-739,

77 Nathan BP, Bellosta S et al.: Differential aspects of apolipoproteins E3 and E4 on neuronal growth in vitro. Sci. 1994, 264, 850-852,

78 Naureckiene S, Sleat DE et al.: Identification of HE1 as the second gene of Niemann-Pick C disease. Sci. 2000, 290, 2298-2301,

79 Norman RM, Forrester RM, Tingey AH: The juvenile form of Niemann-Pick disease. Arch Dis Childh. 1967, 42, 91-96,

80 Notkola IL, Sulkava R et al.: Serum total cholesterol, apoliporotein E epsilon4 allele, and Alzheimer's disease. Neuroepidemiology. 1998, 17, 14-20,

81 Ohm TG, Braak H: Olfactory bulb changes in Alzheimer's disease. Acta neuropathol. 1987, 73, 365-369,

82 Panchuk-Voloshina N, Haugland RP et al.: Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J Histochem Cytochem. 1999, 47, 1179-1188,

83 Papassotiropoulos A, Lütjohann D et al.: 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res. 2002, 36, 27-32,

84 Pearson RCA, Esiri MM et al.: Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci USA. 1985, 82, 4531-4534,

85 Perez M, Cuadros R et al.: Phosphorylated, but not native, tau protein assembles following reaction wih the lipid peroxidation product, 4-hydroxy-2-nonenal. FEBS Lett. 2000, 486, 270-274,

86 Poirier J: Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. TINS. 1994, 17, 525-530,


[Seite 57↓]

87 Poirier J, Baccichet A et al.: Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neurosci. 1993, 55, 81-90,

88 Poirier J, DavignonJ et al.: Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993, 342, 697-699,

89 Probst A, Langui D, Ulrich J: Alzheimer's disease: a description of the structural lesions. Brain Pathol. 1991, 1, 229-239,

90 Raina AK, Hochman A et al.: Abortive apoptosis in Alzheimer's disease. Acta neuropathol. 2001, 101, 305-310,

91 Richmond W: Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem. 1973, 19, 1350-1356,

92 Sawamura N, Gong JS et al.: Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice. J Biol Chem. 2001, 276, 10314-10319,

93 Schroeder F, Holland JF, Bieber LL: Fluorometric investigations of the interaction of polyene antibiotics with sterols. Biochemistry. 1972, 11, 3105-3111,

94 Sevanian A, McLeod LL: Cholesterol autoxidation in phospholipid membrane bilayers. Lipids. 1987, 22, 627-636,

95 Severs NJ, Robenek H: Detection of microdomains in biomembranes. Biochim Biophys Acta. 1983, 737, 373-408,

96 Simons K, Ikonen E: How cells handle cholesterol. Sci. 2000, 290, 1721-1726,

97 Sparks DL: Coronary heart disease, hypertension, apoE, and cholesterol: a link to Alzheimer's disease?. Ann N Y Acad Sci. 1997, 826, 128-146,

98 Spillantini MG, Goedert M: Tau protein pathology in neurodegenerative diseases. TINS. 1998, 21, 428-433,

99 Sumpter PQ, Mann DMA et al.: An ultrastructural analysis of the effects of accumulation of neurofibrillary tangles in pyramidal neurons of the cerebral cortex in Alzheimer's disease. Neuropathol Appl Neurobiol. 1986, 12, 305-319,

100 Suzuki K, Parker CC et al.: Neurofibrillary tangles in Niemann-Pick disease type C. Acta neuropathol. 1995, 89, 227-238,

101 Svennerholm L, Gottfries CG: Membrane lipids, selectively diminished in Alzheimer brains, suggest synpase loss as a primary event in early-onset form (type 1) and demyelination in late-onset form (type 2). J Neurochem. 1994, 62, 1039-1047,

102 Vanier MT: Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem Res. 1999, 24, 481-489,


[Seite 58↓]

103 Vanier MT, Rodriguez-Lafrasse C et al.: Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity. Dev Neurosci. 1991, 13, 307-314,

10 4 Vanier MT, Suzuki K: Recent advances in elucidating Niemann-Pick C disease. Brain Pathol. 1998, 8, 163-174,

105 Vedder H, Anthes N et al.: Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J Neurochem. 1999, 72, 2531-2538,

106 Weaver CL, Espinoza M et al.: Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging. 2000, 21, 719-727,

107 Weis S, Weber G: Handbuch Morbus Alzheimer. Weinheim, 1997

108 Wilson DM, Binder LI: Free fatty acids stimulate the polymerization of tau and amyloid beta peptides - in vitro evidence for a common effector of pathogenesis in Alzeimer's disease. Am J Pathol. 1997, 150, 2181-2195,

109 Wisniewski K, Jervis GA et al.: Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol. 1979, 5, 288-294,

110 Wolozin B, Kellman W et al.: Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch Neurol. 2000, 57, 1439-1443,

111 Yamada A, Saji M et al.: Progressive neuronal loss in the ventral posterior lateral and medial nuclei of thalamus in Niemann-Pick disease type C mouse brain. Brain Dev. 2001, 23, 288-297,

112 Yang Y, Geldmacher DS, Herrup K: DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci. 2001, 21, 2661-2668,

113 Yoshitake T, Kiyohara Y et al.: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology. 1995, 45, 1161-1168,

114 Zervas M, Dobrenis K, Walkley SU: Neurons in Niemann-Pick disease type C accumulate ganglioside as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol. 2001, 60, 49-64.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
19.11.2003